|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Biomarkers, type II collagen, glucosamine and chondroitin sulfate in osteoarthritis follow- up: the 'Magenta osteoar- thritis study' 显示文摘 | Scarpellini M Lurati A Vignati G | 2008 | J Orthopaed Traumatol2008，9，： | 1 |
| 2 | Macrophage activation syndrome(MAS)during anti-IL1 receptor therapy(anakinra)in a patient affected by systemic onset idiopathic juvenile arthritis(soJIA)a report and review of the literature显示文摘 | Lurati A Teruzzi B Salmaso A | 2005 | Pediatr Rheumatol Online J2005，3，2： | 1 |
| 3 | Biomark- ers, type Ⅱ collagen, glucosamine and chondroitin sulfate in os- teoarthritis follow-up: the ' Magenta osteoarthritis study显示文摘 | SCARPELLINI M LURATI A VIGNATI G | 2008 | J Orthopaed Traumatol2008，9，2： | 1 |
| 4 | A comparison of response criteria to evaluate therapeutic response in patients with juve- nile idiopathic arthritis treated with methotrexate and/or an- ti-tumor necrosis factor alpha agents 显示文摘 | Lurati A Pontikaki I Teruzzi B | 2006 | Arthritis Rheum2006，54，5： | 1 |
| 5 | Efficacy of infusions of anti-TNF antibody(infliximab) in persistently active refractory juvenile idiopathic arthritis:results of a two year open label prospective study显示文摘 | Lurati A Gattinara M | 2003 | Arthritis Rheum2003，48，： | 1 |
| 6 | A Comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti - tumor necrosis factor agents显示文摘 | Lurati A Pontikaki I Teruzzi B | 2006 | Arthritis Rheum2006，54，5： | 1 |
| 7 | Biomarkers, type collagen, glucosamine and chondroitin sulfate in osteoarthritis followup: the'Magenta osteoarthritis study显示文摘 | Scarpellini M Lurati A Vignati G | 2008 | J Orthopaed Traumatol2008，9，2： | 1 |
| 8 | Biomarkers, type II colla- gen, glucosamine and chondroitin sulfate in osteoarthritis follow- up: the 'Magenta osteoarthritis study'显示文摘 | Scarpellini M Lurati A Vignati G | 2008 | J Orthop Traumatol2008，9，： | 1 |
| 9 | Macrophage activation syndrome (MAS) during anti IL1 receptor therapy (anakinra) in a patient affected by systemic onset idiopathic juvenile arthritis (soJIA)显示文摘 | Lurati A Teruzzi B Salmaso A | 2005 | Pediatr Rteumatol Online J2005，3，2： | 1 |
| 10 | Biomarkers,type II col agen,glucosamine and chondroitin sulfate in osteoarthritis fol ow-up:the Magenta osteoarthritis study显示文摘 | Scarpel ini M Lurati A Vignati G | | 0，，02： | 1 |
| 11 | Efficacy ofinfusions of anti-TNF antibody(inflixinab)in persistently activerefractory juvenile idiopathic arthritis:results of a two year openlabel prospective study显示文摘 | Gerloni V Lurati A Gattinara M | 2003 | Arthritis Rheum2003，48，： | 1 |
| 12 | The predictive ability of pre-operative B-type natriuretic peptide in vascular patients for major ad-verse cardiac events:an individual patient data meta-analysis显示文摘 | RODSETH R N LURATI BUSE G A BOLLIGER D | 2011 | J Am Coll Cardiol2011，58，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员